Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cellsYichun Zheng, Hiroshi Miyamoto|Endocrine Related Cancer|2011Cited by 103
Androgen receptor activity modulates responses to cisplatin treatment in bladder cancerEiji Kashiwagi, Hiroshi Miyamoto|Oncotarget|2016Cited by 71
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Up-regulates Interleukin-6 in Cancer Cells and Induces Subsequent Development of Interstitial PneumoniaYukari Ishiguro, Hiroshi Miyamoto|Oncotarget|2013Cited by 42
Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expressionEiji Kashiwagi, Hiroshi Miyamoto|British Journal of Cancer|2017Cited by 42
ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signalingSatoshi Inoue, Hiroshi Miyamoto|Endocrine Connections|2018Cited by 33